US Stock MarketDetailed Quotes

UPC Universe Pharmaceuticals

Watchlist
  • 2.5900
  • +0.0800+3.19%
Close May 17 16:00 ET
9.44MMarket Cap-1523P/E (TTM)

Universe Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2023
(FY)Sep 30, 2022
(FY)Sep 30, 2021
(FY)Sep 30, 2020
(FY)Sep 30, 2019
(FY)Sep 30, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
185.35%1.12M
36.17%-1.31M
-133.62%-2.06M
-53.69%6.12M
196.34%13.2M
4.46M
Net income from continuing operations
29.46%-6.16M
-177.18%-8.74M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
--7.6M
Operating gains losses
-108.15%-38.42K
298.10%471.46K
---237.99K
----
--2.09K
----
Depreciation and amortization
-4.71%508.79K
19.48%533.95K
8.97%446.88K
-2.00%410.08K
-7.58%418.43K
--452.73K
Deferred tax
212.28%679.59K
9.44%-605.28K
-6,660.48%-668.34K
75.05%-9.89K
-325.94%-39.63K
--17.54K
Change In working capital
0.50%6.62M
151.94%6.59M
-579.87%-12.69M
-136.16%-1.87M
246.10%5.16M
---3.53M
-Change in receivables
404.53%4.72M
59.94%-1.55M
5.84%-3.87M
-717.22%-4.11M
123.64%665.49K
---2.82M
-Change in inventory
-7,237.48%-1.18M
103.67%16.59K
-150.82%-451.63K
-84.09%888.61K
1,806.96%5.59M
---327.26K
-Change in prepaid assets
-89.30%921.01K
181.50%8.6M
-85,190.94%-10.56M
246.85%12.41K
-128.79%-8.45K
--29.35K
-Change in payables and accrued expense
549.20%2.17M
-122.02%-482.27K
63.38%2.19M
223.84%1.34M
-158.32%-1.08M
---419.06K
Cash from discontinued investing activities
Operating cash flow
185.35%1.12M
36.17%-1.31M
-133.62%-2.06M
-53.69%6.12M
196.34%13.2M
--4.46M
Investing cash flow
Cash flow from continuing investing activities
98.87%-44.17K
85.56%-3.91M
-52,141.32%-27.06M
39.79%-51.8K
40.71%-86.03K
-145.1K
Net PPE purchase and sale
52.60%-44.17K
99.31%-93.18K
-26,023.06%-13.53M
39.79%-51.8K
40.71%-86.03K
---145.1K
Net business purchase and sale
--0
---3.81M
--0
----
----
----
Net investment purchase and sale
--0
--0
---13.53M
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
98.87%-44.17K
85.56%-3.91M
-52,141.32%-27.06M
39.79%-51.8K
40.71%-86.03K
---145.1K
Financing cash flow
Cash flow from continuing financing activities
-141.91%-1.39M
-87.52%3.32M
5,554.07%26.58M
102.94%470.14K
-225.64%-16M
-4.91M
Net issuance payments of debt
--1.7M
--0
68.57%1.54M
79,620.03%911.2K
100.06%1.14K
---1.85M
Net common stock issuance
--0
--0
--28.75M
--0
--0
----
Cash dividends paid
----
----
----
--0
-423.04%-16.01M
---3.06M
Net other financing activities
-193.19%-3.09M
189.57%3.32M
-739.83%-3.7M
---441.06K
----
----
Cash from discontinued financing activities
Financing cash flow
-141.91%-1.39M
-87.52%3.32M
5,554.07%26.58M
102.94%470.14K
-225.64%-16M
---4.91M
Net cash flow
Beginning cash position
-29.30%5.71M
-19.69%8.08M
216.56%10.06M
-48.67%3.18M
-11.36%6.19M
--6.98M
Current changes in cash
83.46%-314.73K
24.92%-1.9M
-138.78%-2.53M
326.38%6.53M
-377.78%-2.89M
---604.08K
Effect of exchange rate changes
75.97%-111.48K
-183.79%-463.94K
59.39%553.7K
374.14%347.39K
33.01%-126.72K
---189.16K
End cash Position
-7.46%5.29M
-29.30%5.71M
-19.69%8.08M
216.56%10.06M
-48.67%3.18M
--6.19M
Free cash flow
176.52%1.08M
90.98%-1.41M
-357.07%-15.59M
-53.78%6.06M
204.31%13.12M
--4.31M
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Sep 30, 2023(FY)Sep 30, 2022(FY)Sep 30, 2021(FY)Sep 30, 2020(FY)Sep 30, 2019(FY)Sep 30, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 185.35%1.12M36.17%-1.31M-133.62%-2.06M-53.69%6.12M196.34%13.2M4.46M
Net income from continuing operations 29.46%-6.16M-177.18%-8.74M49.77%11.32M0.09%7.56M-0.68%7.55M--7.6M
Operating gains losses -108.15%-38.42K298.10%471.46K---237.99K------2.09K----
Depreciation and amortization -4.71%508.79K19.48%533.95K8.97%446.88K-2.00%410.08K-7.58%418.43K--452.73K
Deferred tax 212.28%679.59K9.44%-605.28K-6,660.48%-668.34K75.05%-9.89K-325.94%-39.63K--17.54K
Change In working capital 0.50%6.62M151.94%6.59M-579.87%-12.69M-136.16%-1.87M246.10%5.16M---3.53M
-Change in receivables 404.53%4.72M59.94%-1.55M5.84%-3.87M-717.22%-4.11M123.64%665.49K---2.82M
-Change in inventory -7,237.48%-1.18M103.67%16.59K-150.82%-451.63K-84.09%888.61K1,806.96%5.59M---327.26K
-Change in prepaid assets -89.30%921.01K181.50%8.6M-85,190.94%-10.56M246.85%12.41K-128.79%-8.45K--29.35K
-Change in payables and accrued expense 549.20%2.17M-122.02%-482.27K63.38%2.19M223.84%1.34M-158.32%-1.08M---419.06K
Cash from discontinued investing activities
Operating cash flow 185.35%1.12M36.17%-1.31M-133.62%-2.06M-53.69%6.12M196.34%13.2M--4.46M
Investing cash flow
Cash flow from continuing investing activities 98.87%-44.17K85.56%-3.91M-52,141.32%-27.06M39.79%-51.8K40.71%-86.03K-145.1K
Net PPE purchase and sale 52.60%-44.17K99.31%-93.18K-26,023.06%-13.53M39.79%-51.8K40.71%-86.03K---145.1K
Net business purchase and sale --0---3.81M--0------------
Net investment purchase and sale --0--0---13.53M--0--0----
Cash from discontinued investing activities
Investing cash flow 98.87%-44.17K85.56%-3.91M-52,141.32%-27.06M39.79%-51.8K40.71%-86.03K---145.1K
Financing cash flow
Cash flow from continuing financing activities -141.91%-1.39M-87.52%3.32M5,554.07%26.58M102.94%470.14K-225.64%-16M-4.91M
Net issuance payments of debt --1.7M--068.57%1.54M79,620.03%911.2K100.06%1.14K---1.85M
Net common stock issuance --0--0--28.75M--0--0----
Cash dividends paid --------------0-423.04%-16.01M---3.06M
Net other financing activities -193.19%-3.09M189.57%3.32M-739.83%-3.7M---441.06K--------
Cash from discontinued financing activities
Financing cash flow -141.91%-1.39M-87.52%3.32M5,554.07%26.58M102.94%470.14K-225.64%-16M---4.91M
Net cash flow
Beginning cash position -29.30%5.71M-19.69%8.08M216.56%10.06M-48.67%3.18M-11.36%6.19M--6.98M
Current changes in cash 83.46%-314.73K24.92%-1.9M-138.78%-2.53M326.38%6.53M-377.78%-2.89M---604.08K
Effect of exchange rate changes 75.97%-111.48K-183.79%-463.94K59.39%553.7K374.14%347.39K33.01%-126.72K---189.16K
End cash Position -7.46%5.29M-29.30%5.71M-19.69%8.08M216.56%10.06M-48.67%3.18M--6.19M
Free cash flow 176.52%1.08M90.98%-1.41M-357.07%-15.59M-53.78%6.06M204.31%13.12M--4.31M
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg